Diabetes mellitus, type 2 Trials in Kuala Lumpur, Malaysia
Conditions / Diabetes mellitus, type 2 / Kuala Lumpur, Malaysia
Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.
44 total trials for this combination
Showing top 10 of 44 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01897532 | Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) | COMPLETED | PHASE4 |
| NCT01042769 | A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT01032629 | CANVAS - CANagliflozin cardioVascular Assessment Study | COMPLETED | PHASE3 |
| NCT01541215 | Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT02065791 | Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy | COMPLETED | PHASE3 |
| NCT01720446 | Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01959529 | A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events | COMPLETED | PHASE3 |
| NCT00968708 | Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome | COMPLETED | PHASE3 |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |